4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-17-016766
CIK 0001114220operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:14 PM ET
Size
7.2 KB
Accession
0000899243-17-016766
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Award
Stock Options (right to buy)
2017-06-09+30,000→ 30,000 totalExercise: $6.56From: 2018-06-09Exp: 2027-06-09→ Common Stock (30,000 underlying) - Award
Common Stock
2017-06-09+10,000→ 170,000 total
Footnotes (3)
- [F1]The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 9, 2018, June 9, 2019 and June 9, 2020.
- [F2]Includes 26,665 shares of restricted stock.
- [F3]The 30,000 stock options vest as to one-third on each of June 9, 2018, June 9, 2019 and June 9, 2020.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:14 PM ET
- Size
- 7.2 KB